D3 Bio
Wuxi Shi
About D3 Bio
D3 Bio is a biotechnology company that focuses on discovering and creating medications in oncology and immunology. The company combines clinical and market data to identify shortcomings in existing conventional medicines, employs unique drug development methodologies aimed at new disease targets and delivery routes, and provides patients with therapy alternatives in immunology and oncology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $370.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Dec 2025)
- Website: d3bio.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/d3-bio-114315 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.